Valuation: PharmaEssentia Corporation

Market Cap 52TCr 1.6TCr 1.41TCr 1.3TCr 1.2TCr 2.26TCr 1,53200Cr 2.32TCr 16TCr 6.08TCr 75TCr 6.01TCr 5.88TCr 2,60200Cr P/E 2026 *
48x
P/E 2027 * 34.9x
Enterprise Value 49TCr 1.52TCr 1.33TCr 1.24TCr 1.14TCr 2.15TCr 1,45300Cr 2.2TCr 15TCr 5.77TCr 71TCr 5.7TCr 5.58TCr 2,46800Cr EV / Sales 2026 *
19.5x
EV / Sales 2027 * 13.9x
Free-Float
75.38%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-2.72%
1 week-0.60%
Current month+3.48%
1 month+46.11%
3 months+114.64%
6 months+168.20%
Current year+195.02%
1 week 1,230
Extreme 1230
1,415.34
1 month 854.61
Extreme 854.6101
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - 01/08/2022
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-2.72%-0.60%+187.08%+351.91% 1.65TCr
-2.48%-3.13%+55.85%+89.65% 5.49TCr
-0.55%-8.57%+58.09%+124.47% 5.46TCr
-5.60%-2.20%+11.16%+437.37% 2.51TCr
-1.55%-7.66%-20.21%-17.37% 2.31TCr
-1.69%-0.64%+40.04%-0.48% 1.99TCr
+1.87%+1.87%+38.13%-26.14% 1.75TCr
-2.42%+1.00%+48.24%+635.77% 1.57TCr
-0.81%+0.34%+24.92%+189.31% 1.42TCr
-1.06%+0.55%+68.33%+140.84% 1.24TCr
Average -1.70%-0.57%+51.16%+192.53% 2.54TCr
Weighted average by Cap. -1.77%-1.41%+49.47%+165.63%

Financials

2026 *2027 *
Net sales 2.51TCr 78Cr 68Cr 63Cr 58Cr 110.12Cr 7.45TCr 112.68Cr 756.21Cr 295.98Cr 3.65TCr 292.47Cr 286.19Cr 13TCr 3.46TCr 107.44Cr 94Cr 87Cr 80Cr 151.84Cr 10TCr 155.38Cr 1.04TCr 408.13Cr 5.04TCr 403.28Cr 394.62Cr 17TCr
Net income 1.09TCr 34Cr 30Cr 27Cr 25Cr 48Cr 3.23TCr 49Cr 327.44Cr 128.16Cr 1.58TCr 126.64Cr 123.92Cr 5.48TCr 1.5TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.45TCr 67Cr 451.64Cr 176.77Cr 2.18TCr 174.67Cr 170.92Cr 7.56TCr
Net Debt -2.65TCr -82Cr -72Cr -67Cr -62Cr -116.51Cr -7.88TCr -119.23Cr -800.14Cr -313.18Cr -3.87TCr -309.46Cr -302.81Cr -13TCr -3.47TCr -107.95Cr -95Cr -88Cr -81Cr -152.55Cr -10TCr -156.11Cr -1.05TCr -410.04Cr -5.06TCr -405.17Cr -396.47Cr -18TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
13/26/13 NT$1,250.00 -2.72% 33,73,173
09/26/09 NT$1,285.00 -6.84% 67,11,957
08/26/08 NT$1,379.28 +2.34% 47,71,223
07/26/07 NT$1,347.72 +3.46% 39,59,953
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,250.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-15.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock